Abstract
Influenza virus is the pathogen responsible for the epidemic influenza and current vaccines include inactivated and live attenuated viruses which are produced in chicken eggs. However, these vaccines posses various drawbacks of their own and the protection rate ranges from 30-80% depending on match between strains included in the vaccine and circulating strains, leaving significant room for improvement. This review provides background information regarding the influenza vaccines and extends the discussion with an emphasis on the new patents published or granted over the last five years. These patents primarily aim at ameliorating existing bottlenecks in vaccine development and are associated with vaccine compositions that provide strong vaccine efficacies and broader cross-reactivity, and various vaccine platforms such as DNA vaccines, recombinant subunit, peptide and viral vector vaccines.
Keywords: Influenza vaccine, influenza virus, DNA vaccine, inactivated virus vaccine, attenuated virus, reverse genetics, adjuvant, subunit vaccine, peptide vaccine
Recent Patents on Biotechnology
Title: Recent Patents on Influenza Vaccines
Volume: 1 Issue: 3
Author(s): Yu-Chen Hu and Chi-Yuan Chen
Affiliation:
Keywords: Influenza vaccine, influenza virus, DNA vaccine, inactivated virus vaccine, attenuated virus, reverse genetics, adjuvant, subunit vaccine, peptide vaccine
Abstract: Influenza virus is the pathogen responsible for the epidemic influenza and current vaccines include inactivated and live attenuated viruses which are produced in chicken eggs. However, these vaccines posses various drawbacks of their own and the protection rate ranges from 30-80% depending on match between strains included in the vaccine and circulating strains, leaving significant room for improvement. This review provides background information regarding the influenza vaccines and extends the discussion with an emphasis on the new patents published or granted over the last five years. These patents primarily aim at ameliorating existing bottlenecks in vaccine development and are associated with vaccine compositions that provide strong vaccine efficacies and broader cross-reactivity, and various vaccine platforms such as DNA vaccines, recombinant subunit, peptide and viral vector vaccines.
Export Options
About this article
Cite this article as:
Hu Yu-Chen and Chen Chi-Yuan, Recent Patents on Influenza Vaccines, Recent Patents on Biotechnology 2007; 1 (3) . https://dx.doi.org/10.2174/187220807782330192
DOI https://dx.doi.org/10.2174/187220807782330192 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
Call for Papers in Thematic Issues
Advancements in Plant Genetics and Genomics
This thematic issue will highlight cutting-edge innovations and recent patents across the breadth of plant genetics and genomics. Key topics will include advanced breeding techniques, omics-based approaches, gene editing, trait discovery, and translational applications for crop improvement. Renowned researchers from leading institutions worldwide will provide state-of-the-art insights and future perspectives ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Depot Based Drug Delivery System for the Management of Depression
Current Drug Delivery The Design of Amphiphilic Polymeric Micelles of Curcumin for Cancer Management
Current Medicinal Chemistry LPA and its Analogs-Attractive Tools for Elucidation of LPA Biology and Drug Development
Current Medicinal Chemistry Disorders of Protein Biogenesis and Stability
Protein & Peptide Letters Molecular Markers of Angiogenesis and Metastasis in Lines of Oral Carcinoma after Treatment with Melatonin
Anti-Cancer Agents in Medicinal Chemistry Decoding the Knots of Initiation of Oncogenic Epithelial-Mesenchymal Transition in Tumor Progression
Current Cancer Drug Targets Role of Focal Adhesion Kinase in Human Cancer: A Potential Target for Drug Discovery
Anti-Cancer Agents in Medicinal Chemistry Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option
Current Topics in Medicinal Chemistry Identification of Key mRNAs, miRNAs, and mRNA-miRNA Network Involved in Papillary Thyroid Carcinoma
Current Bioinformatics Redox Environment and its Meaning for Breast Cancer Cells Fate
Current Cancer Drug Targets Anesthesia for Bronchoscopy
Current Pharmaceutical Design Melatonin Induces Apoptosis and Inhibits the Proliferation of Cancer Cells via Reactive Oxygen Species-mediated MAPK and mTOR Pathways
Clinical Cancer Drugs The Use of PET for Radiotherapy
Current Medical Imaging Looking at Drug Resistance Mechanisms for Microtubule Interacting Drugs: Does TUBB3 Work?
Current Cancer Drug Targets Design, Synthesis and Evaluation of Hybrid 2-Heteroaryl Benzimidazole- Chalcone Derivatives as Anticancer Agents
Letters in Organic Chemistry CBP-dependent Wnt/β-catenin signaling is crucial in regulation of MDR1 transcription
Current Cancer Drug Targets Novel Implications for Lysophospholipids, Lysophosphatidic Acid and Sphingosine 1-Phosphate, as Drug Targets in Cancer
Anti-Cancer Agents in Medicinal Chemistry The Recombinant T Cell Receptor Strategy: Insights into Structure and Function of Recombinant Immunoreceptors on the Way Towards an Optimal Receptor Design for Cellular Immunotherapy
Current Gene Therapy How to Manage the Infectious Risk under Anti-TNF in Inflammatory Bowel Disease
Current Drug Targets Heterocyclic Chalcone Analogues as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry